Jennifer S. Guimbellot

Also affiliated with University of Arkansas Medical Center, University of Alabama at Birmingham, Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Ivacaftor for Chronic Obstructive Pulmonary Disease: Results from a Phase 2, Randomized Controlled Trial”.

Ivacaftor for Chronic Obstructive Pulmonary Disease: Results from a Phase 2, Randomized Controlled Trial

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202407-1302oc

N/A

0.374DataRank · unranked

5 citations

George M. Solomon, Jennifer S. Guimbellot, Edward P. Acosta, Pradeep G. Bhambhavni, Sharon White +9 more

Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.05.008

N/A

0DataRank · unranked

22 citations

Kevin J. Ryan, Hector Gutierrez, Luz Helena Gutierrez Sanchez, Janaina Nogueira Anderson, Edward P. Acosta +3 more

Combination CFTR modulator therapy in children and adults with cystic fibrosis

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00176-4

N/A

0DataRank · unranked

9 citations

Jennifer L. Taylor‐Cousar, Jennifer S. Guimbellot

Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.04.009

N/A

0DataRank · unranked

47 citations

Jennifer S. Guimbellot, Maryam Valapour, Lauren Bartlett, Travis Hee Wai, Christopher H. Goss +4 more

Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate

Journal of Chromatography B(2022)10.1016/j.jchromb.2022.123518

N/A

0DataRank · unranked

21 citations

Jennifer S. Guimbellot, Alexander E. Dowell, Kedria D. Reed-Walker, Corenna Kerstner-Wood, Justin D. Anderson +3 more

Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis

Pediatric Pulmonology(2022)10.1002/ppul.26093

N/A

0DataRank · unranked

11 citations

Kevin J. Ryan, Justin D. Anderson, Kennedy L. Parker, L. Victoria Odom, Steven M. Rowe +2 more

Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis

Clinics in Chest Medicine(2022)10.1016/j.ccm.2022.06.005

N/A

0DataRank · unranked

5 citations

David P. Nichols, John J. Brewington, Jennifer S. Guimbellot

Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells

PLoS ONE(2023)10.1371/journal.pone.0295009

N/A

0DataRank · unranked

19 citations

Zhong Liu, Justin D. Anderson, Zhongyu Liu, Liping Tang, Li Yao +10 more

Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis

Clinical and Translational Science(2023)10.1111/cts.13479

N/A

0DataRank · unranked

11 citations

Brittney H. Davis, Gracie Giang, April Jones, Cameron R. Lee, Kennedy L. Parker +5 more

Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.09.017

N/A

0DataRank · unranked

2 citations

Lauren Bartlett, Jennifer S. Guimbellot, T. Milinic, Nora Burdis, Eliana R Gill +5 more

440 Ivacaftor metabolites in epithelia

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01366-8

N/A

0DataRank · unranked

0 citations

A. Dowell, Kevin J. Ryan, J. Anderson, Edward P. Acosta, Jennifer S. Guimbellot

606 Social determinants of overweight and obesity in children with cystic fibrosis in the United States: a longitudinal analysis of Cystic Fibrosis Foundation Patient Registry data (2009-2019)

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01528-x

N/A

0DataRank · unranked

0 citations

Jonathan Bailey, Michael S. Schechter, Jennifer S. Guimbellot, Gabriela R. Oates, Elizabeth Baker

Pharmacokinetic variability of CFTR modulators from standard and alternative regimens

Pulmonary Pharmacology & Therapeutics(2024)10.1016/j.pupt.2024.102301

N/A

0DataRank · unranked

11 citations

A. Chalamalla, Bryan Garcia, Stefanie Krick, Jonathan Bergeron, Hossein Sadeghi +6 more

Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.07.010

N/A

0DataRank · unranked

4 citations

William T. Harris, Jennifer S. Guimbellot, Kyle Bliton, Steven M. Rowe, S. Vamsee Raju +2 more

Evaluating the effects of ivacaftor exposure on Staphylococcus aureus small colony variant development and antibiotic tolerance

JAC-Antimicrobial Resistance(2024)10.1093/jacamr/dlae185

N/A

0DataRank · unranked

2 citations

Kendall M Shaffer, Johnathan D. Keith, Ashley M. Oden, Alexander E. Dowell, Kevin J. Ryan +5 more

Pilot and feasibility study of dietary composition with elexacaftor‐tezacaftor‐ivacaftor concentrations in people with cystic fibrosis

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2024)10.1002/phar.4630

N/A

0DataRank · unranked

2 citations

Julianna Bailey, Justin D. Anderson, A. Chalamalla, Kevin J. Ryan, Edward P. Acosta +2 more

Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia

Pulmonary Pharmacology & Therapeutics(2024)10.1016/j.pupt.2024.102314

N/A

0DataRank · unranked

1 citations

Justin D. Anderson, Natalie R. Rose, Elizabeth Baker, Alexander E. Dowell, Kevin J. Ryan +3 more

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.015

N/A

0DataRank · unranked

17 citations

Dara Riva, Yair J. Blumenfeld, John F. Engelhardt, Carmen Luna‐Paredes, Carlos Milla +17 more

Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.05.002

N/A

0DataRank · unranked

6 citations

Elizabeth Baker, Jennifer S. Guimbellot, Joseph M. Collaco, Michael S. Schechter, Gabriela R. Oates +1 more

Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.11.008

N/A

0DataRank · unranked

64 citations

Arthur Baines, Alex Paynter, Sonya L. Heltshe, Jill M. VanDalfsen, Manu Jain +3 more

Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.03.010

N/A

0DataRank · unranked

2 citations

A. Chalamalla, Elizabeth Baker, Kevin J. Ryan, Ashley Dowell, Saly Abouelenein +6 more